Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional Accepts healthy volunteers

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

ClinicalTrials.gov ID: NCT06749457

Public ClinicalTrials.gov record NCT06749457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/IIa Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Participants and in Patients With End-stage Kidney Disease Receiving Hemodialysis Through a Central Venous Catheter

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).

Study identification

NCT ID
NCT06749457
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2024 (Actual)
Primary completion
Mar 8, 2027 (Estimated)
Completion
Dec 13, 2027 (Estimated)
Last update posted
Oct 6, 2026

2024 – 2027

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
38
Facility City State ZIP Site status
Research Site Huntsville Alabama 35805 —
Research Site Chula Vista California 91910 —
Research Site Glendale California 91206 —
Research Site Granada Hills California 91344 —
Research Site Los Angeles California 90027 —
Research Site Northridge California 91324 —
Research Site Northridge California 91325 —
Research Site Oxnard California 93036 —
Research Site Riverside California 92503 —
Research Site San Dimas California 91773 —
Research Site Tarzana California 91356 —
Research Site Valencia California 91355 —
Research Site Victorville California 92392 —
Research Site Englewood Colorado 80110 —
Research Site Bradenton Florida 34209 —
Research Site Coral Springs Florida 33071 —
Research Site Hollywood Florida 33024 —
Research Site Orlando Florida 32806 —
Research Site Tampa Florida 33603 —
Research Site Lawrenceville Georgia 30046 —
Research Site Chicago Illinois 60640 —
Research Site Chicago Illinois 60643 —
Research Site Iowa City Iowa 52242 —
Research Site Lexington Kentucky 40503 —
Research Site Baltimore Maryland 21225 —
Research Site Detroit Michigan 48202 —
Research Site Pontiac Michigan 48341 —
Research Site Tupelo Mississippi 38801 —
Research Site Kansas City Missouri 64111 —
Research Site Lincoln Nebraska 68510 —
Research Site Las Vegas Nevada 89128 —
Research Site Jersey City New Jersey 07305 —
Research Site Albuquerque New Mexico 87109 —
Research Site Ridgewood New York 11385 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Bethlehem Pennsylvania 18017 —
Research Site Beaumont Texas 77706 —
Research Site Dallas Texas 75246 —
Research Site Houston Texas 77074 —
Research Site McAllen Texas 78503 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06749457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06749457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →